Measurement of various biosignals with an ultra-compact, low-power solution

Maxim Integrated Korea has launched wearable solutions for disease prevention and fitness: 'MAX86140', 'MAX86141', and 'MAX30001'.

The MAX86140/41 are optical pulse oximeters/heart rate sensors, and the MAX30001 is an analog front end (AFE) for electrocardiogram (ECG) and bioimpedance (BioZ) measurements. Maxim's ultra-small, low-power solutions enable consumers to accurately monitor their health and prevent disease.

Maxim's portfolio of wearable sensors for healthcare and fitness accurately monitors a variety of key biometric signals. These ultra-compact, low-power solutions are designed for both extended battery life and user convenience.

The MAX86140/41 utilize pulse oximetry (PPG) signals from the wrist, finger, and ear to measure heart rate, heart rate variability, and pulse oximetry. The MAX30001 measures electrocardiogram (ECG) and bioimpedance from the chest and wrist to detect heart rate, respiration, and arrhythmia.

The MAX86140/41 are approximately one-third smaller and consume half the power of comparable solutions. The MAX30001 is nearly half the size and uses half the power. Maxim's solutions accurately collect heart data, beat by beat, enabling users to recognize key symptoms early. The MAX30001 complies with the clinical ECG standard IEC60601-2-47.

“The Maxim solution is impressive in that it enables clinical-grade diagnostics in a form factor small enough to be integrated into any type of everyday clothing,” said Adrian Straka, Director of Hardware and Manufacturing at SKIIN, a smart apparel company. “Maxim’s ultra-small MAX30001 enables SKIIN’s biosensing underwear to measure and monitor health 24/7 with low power consumption.”

“Maxim’s robust portfolio of sensor solutions will enable our customers to succeed with superior performance, ultra-small form factors, and high accuracy,” said Andrew Baker, senior director of technology for industrial and healthcare products at Maxim Integrated.